With interest we read the letters written by Prof. Buettner-Janz and Mr. Link, and would like to thank them for their attention paid to our publication.
We re-evaluated our data on the basis of Prof. Buettner-Janz's statement, and found the published numbers of patients and implants within the period of time accounted for to be correct. Hence, between September 21, 1984 and September 10, 1985 16 patients have been treated with 17 type I Charite´total disc replacements (formerly characterized as SB-I). Out of the 16, 15 patients with 16 prostheses could be included in our retrospective evaluation. Therefore, from our point of view, there is no reason to make any changes to the presented statistics. To what extent modifications of small details within the different prototypes of implants have been made, cannot be extracted from the existing documents without doubt 20 years after surgery. The same applies to the alterations of implant materials mentioned.
A follow-up rate of 75% after 17 years is by no means ''highly problematic''. In contrast, it is comparable to numerous other long-term follow-up examinations [2, 4, 8, 10] . Apparently, the editor and the reviewers of the reputable European Spine Journal share this opinion, otherwise they would not have approved the publication of our data in such a highly ranked journal.
Concerning the assessment of the results of the discussed study, it has to be stated that we present results obtained with the operative technique of that time, as well as the formerly defined indications of surgery, and the implants available in the mid-eighties. Only these patients and their results were included, rated, and discussed. Therefore, a comparison to a recent study from
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2005 with a maximum follow-up of 24 months (Blumenthal 2005) does not seem to be meaningful at all.
It can be taken for granted that most of the formerly treated segment pathologies should nowadays be no indication for artificial disc replacement. The operative technique was obviously partly insufficient at that time; particularly some disc replacements that were too small have been implanted. However, to make scientific progress possible, critical dealing with unsatisfactory results is imperatively required. This is the only way to optimise implants and operative techniques. In order to achieve improvements for our patients, continuous development and strict examination of indications and techniques is mandatory. Thus, we have to emphasise that the conclusion of Prof. Buettner-Janz that critical evaluation of scientific results would prevent medical progress, has to be clearly rejected. On the contrary, we are convinced that critical analysis of problems and errors in patient care is inextricably linked to any further development. Especially because of the lack of controlled long-term studies, it is even more important to evaluate retrospective case series with the necessary sincerity and critical accuracy to control the previously obtained knowledge and experience. Only for the reason of publication of early failures and the resulting conclusions and changes made, the procedures quoted by Prof. Buettner-Janz (e.g. organ transplantations and hip and knee arthroplasty) are medical standard nowadays.
The content of both letters confirms that artificial disc replacement until now experiences pronounced evolutionary changes. The indications for surgery are being put in concrete terms, the criteria for the selection of the correct implant are being optimised, the operative technique and the implants are being improved.
We learned that the treated motion segment of the spine has to be considered as a whole. Today, we are able to take into consideration the anatomical and morphological qualities when indicating a procedure in a way, it was impossible in those days. Meanwhile, a number of authors has identified certain pathologies of the dorsal column of the spine-such as pronounced facet joint arthritis or spondylolysis-as contraindication for artificial disc replacement [1, 3, 6, 9] . Our results confirm this impressively. Despite of that, even in recent times, the implantation of artificial discs has been performed with disregard to these important facts as demonstrated in Fig. 1 . In our opinion, it is not acceptable to ignore the resulting clinical consequences for the patients.
Our article shows results of artificial disc replacements in patients with moderate to predominantly severe segmental degeneration. We have to take into consideration, that long-standing degenerative processes in combination with chronic pain will in no case affect the intervertebral disc alone, but a number of other morphological structures. Thus, in these cases it cannot be expected-and our results confirm these expectations-that an exclusive disc replacement therapy will lead to the complete elimination of the patients' complaints. Neither the optimisation of the implants nor the experience of the surgeon can make any changes to this fact.
Furthermore, a spondylophytic bridging of the intervertebral space has to be judged as a reparative process of the spine or as reaction to segmental degeneration. The more severe the progression of the degeneration is, the more evident is this process. Hence, medical experience is confirmed, when after 17 years of Fig. 1 Female patient (35 years). Implantation of a Charite´T M disc at L5/S1 because of ''low back pain'' due to bilateral spondylolysis of L5 in 2002; 4 months after the initial surgery dislocation of the disc follow-up in our group of patients with predominantly severe segmental degeneration prior to surgery, a relatively high rate of secondary fusions was seen, whereas in a group of patients with initial to moderate degeneration this has not been shown. Therefore, it is by no means reasonable, to describe our results as ''dubious''.
Finally, we are convinced that everybody would agree, that from an ethical point of view non-critical application of new procedures in medicine cannot be accepted. For the sake of our patients each new procedure has to be discussed extensively on a scientific base without any personal, commercial or social interest.
